$69.2 Bn In-Vitro Diagnostic Tests Markets, 2024

News provided by

Sep 25, 2019, 11:15 ET

DUBLIN, Sept. 25, 2019 /PRNewswire/ -- The "The Worldwide Market for In Vitro Diagnostic Tests: 12th Edition" report has been added to ResearchAndMarkets.com's offering.

The market for IVD currently stands at $69.2 billion dollars

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry.

What is the Size of the 2019 IVD Market?
How fast will the market grow?
What companies stand to gain?

It is poised for growth over the next five years, improved growth from the last edition of the report. There are hundreds of companies competing in the market in some form and scores of large multi-test players.

This 2,000-page report provides in vitro diagnostics market size estimates and projections:

2000-Page Report Based on Vendor Reporting, Interviews, Vendor Activities
Authored by Veteran IVD Analysts with Industry Knowledge
12 Detailed Market Chapters with 2019 Market Estimate
Relevant Segmentation for Test Business Planners, Investors, New Entrants, and Other Market Watchers
Where is IVD Heading? - Market Segment Projections to 2024
What's Behind the Growth and Declines? - Market Numbers and Analysis
Regional Breakouts Including Country IVD Markets
Sections on China, Europe, Japan, and The United States IVD Markets
Macro Analysis of Major Trends
Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
Used by Major IVD Firms for Business Planning
Coverage of Trends and Market Estimates for Essential IVD Segments: Clinical Chemistry, Point-of-Care, Molecular, Infectious Disease, Histology and More.

In vitro, diagnostic testing costs little to the healthcare system and contributes much to clinical practice. For some time this has been stated as educated conjecture; a recent study of U.S and German physicians offer proof. The study found that 66% of clinical decisions made were based on a diagnostic test, while the costs of those tests were just 2.3% of healthcare expenditure (Rohr U., Binder C, PLoS One. 2016).

When the cost-effectiveness of in vitro diagnostic testing is then considered along with beneficial effects on treatment outcomes, therapy choices, and hospital management, there should be little surprise about the amount of interest in IVDs and the amount of activity in the market for them.

The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2024 for defined segments of the IVD market and various sub-segments, including:

Molecular Assays: Infectious Disease [HIV, Hepatitis, Respiratory, Others] Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal
Clinical Chemistry and Core Lab Markets: General Chemistries, Blood Gases, Urinalysis, Immunos run on Workstations
Point-of-Care Testing (POC): Professional and Self-Testing, Fertility, Colon Cancer, HbA1c POC, Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OT
Glucose Testing: Meters, Professional Testing, Continuous Glucose
Substance Abuse Testing (Employment Screening, Criminal Justice, Critical Care - Traditional POC)
Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
Blood Banking (Typing, Immunoassay Screen, NAT Blood Testing)
Histology and Cytology: Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV
Immunoassay Testing: Infectious Disease, Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c
Hematology
Cardiac Markers, Tumor Markers, Diabetes/hbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs
Coagulation Tests
Direct-to-Consumer Testing

For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2024 projection, and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers' product innovations. The market data is put into a context with real-world industry and medical practice trends.

The IVD Market Opportunity by Country

The in-vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 12th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers' product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included.

Who's In The Market? Who's Winning?

The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that the publisher has in the in vitro diagnostics market is evident in its tiering and segmentation of companies.

Key Topics Covered

Executive Summary
Introduction
The Global Picture for In Vitro Diagnostic Markets
Company and Industry Trends
Point-of-Care Tests
The Core Lab
Immunoassays
Molecular Assays
Hematology
Coagulation
Microbiology and Virology
Blood Banking Services
Histology and Cytology
Company Profiles: The Top Tier
Company Profiles: The Second Tier
Company Profiles: Blood Bank Specialists
Company Profiles: Coagulation Specialists
Company Profiles: Core Lab and Other Companies
Company Profiles: CTC & Liquid Biopsy Test Providers
Diabetes Specialists
Company Profiles: Hematology (Cell Analysis) Specialists
Company Profiles: Histopathology Specialists
Company Profiles: Immunoassay Specialists
Information Technology Specialists in In Vitro Diagnostics
Company Profiles: Microbiology Specialists
Company Profiles: Molecular Test Specialists
Company Profiles: Point of Care Test Specialists
Company Profiles: Prenatal Test Service Providers
Company Profiles: Quality Control & Sample Pretreatment Specialists
Test Service Providers

Companies Mentioned

A. Menarini Diagnostics
AB SCIEX Pte Ltd
Abaxis, Inc.
Abbott Diagnostics
Abingdon Health Ltd.
Accelerate Diagnostics, Inc.
Advanced Biological Laboratories, S.A. (ABL)
Advanced Cell Diagnostics (ACD)
Agilent Technologies
Altona Diagnostics
Amoy Diagnostics Co. Ltd.
Applied Spectral Imaging Inc. (ASI)
ArcDia International Oy Ltd.
Arkray
Asuragen Inc.
Atlas Genetics Ltd. (Binx Health)
AutoGenomics Inc.
Beckman Coulter, Inc. / Danaher
Becton, Dickinson and Company (BD)
BGI Genomics (formerly Beijing Genome Institute)
Biocartis
Biocept, Inc.
Biodesix
BioFire Diagnostics, LLC. (acquired by bioMrieux)
BioGenex Laboratories, Inc.
Biohit Oyj (Biohit Healthcare)
Biomeme, Inc.
Biomerica Inc.
bioMrieux Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioView Ltd.
Bruker BioSciences Corporation
Bruker Corporation
CellaVision AB
Cepheid
Cerner Corp.
Chembio Diagnostic Systems, Inc.
Circulomics Inc.
COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
Corgenix Medical Corporation
Critical Diagnostics
Curetis
Cynvenio Biosystems (LungLife AI)
Dako A/S
Danaher Corporation
Definiens
Dell Technologies Inc.
Desktop Genetics Ltd.
Dexcom Inc.
Diagnostica Stago, S.A.S.
DiaSorin S.p.A
DNA Electronics Ltd (DNAe)
Eiken Chemical Co., Ltd
EKF Diagnostics Holdings Plc
ELITech Group S.A.S.
Entopsis
Enzo Biochem Inc.
Epigenomics AG
ERBA Diagnostics, Inc.
Eurobio Scientific
EUROIMMUN AG
Exosome Diagnostics, Inc.
FABPulous B.V.
Fast Track Diagnostics (acquired by Siemens Healthineers)
Fio Corporation
Fluidigm Corporation
Focus Diagnostics, Inc.
Foundation Medicine, Inc.
Fujirebio Diagnostics, Inc.
Genedrive plc (formerly Epistem Holdings)
Genetic Analysis AS
GenMark Diagnostics, Inc
Genome Diagnostics BV (GenDx)
Genomic Health (Exact Sciences)
Gentag Inc.
Greiner Bio-One International GmbH
Grifols S.A.
Guardant Health, Inc.
Hain Lifescience GmbH
HOB Biotech
Hologic, Inc.
Horiba Medical
HTG Molecular Diagnostics
Illumina
Immunodiagnostic Systems (IDS)
INOVA Diagnostics, Inc.
Instrumentation Laboratory (IL) / Werfen
Kapa Biosystems Inc.
LabCorp, Laboratory Corporation of America
Leica Biosystems
Leica Biosystems
LifeScan Inc.
Luminex Corporation
Mast Group
Medica Corporation
MedTest DX
Medtronic plc
Menarini-Silicon Biosystems
Meridian Bioscience, Inc.
Microsaic Systems plc
MilliporeSigma (formerly EMD Millipore)
Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
Mobidiag Ltd.
Myriad Genetics, Inc.
Nanosphere, Inc. (Luminex)
NanoString Technologies, Inc.
Natera
Nemaura Medical Inc.
NeoGenomics
Nova Biomedical
Nova Biomedical Corporation (Nova)
Onca Xt Ltd
OpGen, Inc.
Ortho Clinical Diagnostics (Ortho)
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California, Inc. (PacBio)
PerkinElmer, Inc. (PE)
Philips (Royal Philips)
PositiveID Corporation
PTS Diagnostics
QIAGEN N.V.
Q-linea AB
QuanDx Inc
QuantuMDx Group, Ltd.
Quest Diagnostics
Quidel Corporation
Radiometer A/S / Danaher
RainDance Technologies, Inc.
Randox Laboratories Ltd.
Rheonix, Inc.
Roche Diagnostics
Rubicon Genomics, Inc.
Samsung Healthcare
Scienion AG
Seegene, Inc.
Sekisui Diagnostics LLC
Shimadzu Scientific Instruments
Siemens Healthineers (Siemens)
Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
Sysmex Corporation
Takara Bio Inc.
Tecan Group
Thermo Fisher Scientific Inc.
Tosoh Bioscience
Trinity Biotech Plc
Trovagene, Inc.
Vela Diagnostics
Ventana Medical Systems Inc. / Roche Tissue Diagnostics
Veredus Laboratories Pte Ltd
WaferGen Bio-systems, Inc.
Werfen
West Medica

For more information about this report visit https://www.researchandmarkets.com/r/4l5wxy

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets